ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984

FDA Approves Generic Capecitabine

September 20, 2013

CTRF Seeks Applications In Clinical Cancer Research.

January 28, 2000

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976